Rv1630 - c.522C>T
Drug resistance types
1 Sensitive
6 RR-TB
0 HR-TB
9 MDR-TB
0 Pre-XDR-TB
0 XDR-TB
4 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.8.1 | 2 |
| lineage4.2.2.2 | 1 |
| La3;lineage4.2;lineage4.6.4;lineage4.9;lineage6.3 | 1 |
| lineage2.2.1 | 2 |
| lineage4.8.2;lineage4.9 | 1 |
| lineage4.9 | 2 |
| lineage4.4.1.1 | 2 |
| lineage4.1.1.3.1;lineage4.9 | 1 |
| lineage4.3.3 | 2 |
| lineage4.1.1.1 | 1 |
| lineage4.4.1.1.1 | 2 |
| La3;lineage4.9 | 1 |
| lineage4.8.2 | 1 |
| La3;M.canetti;lineage4.2;lineage4.6.4;lineage4.9;lineage6.3 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 20 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR11342693 | MDR-TB | lineage4.8.1 | None | SRR11342687 | RR-TB | lineage4.2.2.2 | None | ERR5311091 | Other | La3;lineage4.2;lineage4.6.4;lineage4.9;lineage6.3 | None | SRR11342653 | MDR-TB | lineage2.2.1 | None | SRR5007168 | Other | lineage4.8.2;lineage4.9 | None | SRR1735598 | RR-TB | lineage4.9 | None | ERR4818851 | RR-TB | lineage4.4.1.1 | None | SRR11342662 | MDR-TB | lineage4.8.1 | None | SRR5007161 | RR-TB | lineage4.1.1.3.1;lineage4.9 | None | SRR11342649 | MDR-TB | lineage4.3.3 | None | SRR11342651 | MDR-TB | lineage4.1.1.1 | None | SRR11342644 | MDR-TB | lineage4.4.1.1.1 | None | SRR6153140 | Sensitive | lineage4.4.1.1 | ca | SRR28119827 | Other | La3;lineage4.9 | None | SRR1735596 | RR-TB | lineage4.9 | None | SRR5007169 | RR-TB | lineage4.8.2 | None | SRR11342660 | MDR-TB | lineage2.2.1 | None | SRR6046482 | Other | La3;M.canetti;lineage4.2;lineage4.6.4;lineage4.9;lineage6.3 | None | SRR11342636 | MDR-TB | lineage4.3.3 | None | SRR11342696 | MDR-TB | lineage4.4.1.1.1 | None |
|---|
